Skip to main content

Table 6 Number of patients with dyspeptic symptoms at baseline and study end, stratified by baseline severity of symptoms (full analysis set)

From: Safety and efficacy of long-term esomeprazole 20 mg in Japanese patients with a history of peptic ulcer receiving daily non-steroidal anti-inflammatory drugs

Symptom   Baseline
  Study end None Mild–Severe
Epigastric pain None 100 18
Mild–Severe 8 4
Stomach discomfort None 102 14
Mild–Severe 5 9
Abdominal fullness None 100 18
Mild–Severe 4 8
Nausea/vomiting None 116 8
  Mild–Severe 4 2
Heartburn None 112 14
  Mild–Severe 3 1
Anorexia None 111 10
  Mild–Severe 7 2